The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results.
 
Joseph Aloysius Ludwig
No Relationships to Disclose
 
Noah C. Federman
Stock and Other Ownership Interests - Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Loxo; Zelda Therapeutics
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics
 
Peter Meade Anderson
Stock and Other Ownership Interests - Healios
Consulting or Advisory Role - Enlivity
Research Funding - Oncoceutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent “glutamine & trehalose compositions Priority date 13-Sept 2013; ”App 14/470, 545 filed AUG 27, 2014 patent 61/878,084 issued Dec-26, 2017
Other Relationship - Enlivity
 
Margaret E Macy
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - Ymabs Therapeutics Inc
Research Funding - Bayer (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi Sankyo; Deciphera; Ignyta; Loxo; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Philogen (Inst); Plexxikon (Inst); Roche/Genentech (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Lara E. Davis
Consulting or Advisory Role - Daiichi Sankyo; Epizyme
 
Najat C. Daw
Consulting or Advisory Role - Bayer; Incyte
 
Jade Wulff
No Relationships to Disclose
 
AeRang Kim
No Relationships to Disclose
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - touchIME
Consulting or Advisory Role - Epizyme
Research Funding - SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Edwina S Baskin-Bey
Leadership - Catalyst Clinical Research
Stock and Other Ownership Interests - Catalyst Clinical Research; Oncternal Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Geistlich Pharma; Green3Bio; Oncternal Therapeutics
Travel, Accommodations, Expenses - Geistlich Pharma
 
Jeffrey A. Toretsky
Stock and Other Ownership Interests - Oncternal Therapeutics
Consulting or Advisory Role - Oncternal Therapeutics; Tokalas
Patents, Royalties, Other Intellectual Property - have IP as Georgetown faculty member
 
James Bradley Breitmeyer
Employment - Oncternal Therapeutics, Inc
Leadership - Oncternal Therapeutics, Inc; Otonomy; Zogenix
Stock and Other Ownership Interests - Oncternal Therapeutics, Inc; Oncternal Therapeutics, Inc (I); Otonomy; Zogenix
Patents, Royalties, Other Intellectual Property - Inventor on patent(s)
Travel, Accommodations, Expenses - Oncternal Therapeutics, Inc; Zogenix
 
Paul A. Meyers
Stock and Other Ownership Interests - Amgen
Honoraria - Eastern Pulmonary Conference (I); France Foundation (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Salarius Pharmaceuticals
Speakers' Bureau - France Foundation (I); Genentech/Roche (I)
Travel, Accommodations, Expenses - InterMune (I); Takeda